Thursday, August 16, 2018

Tyrosine kinase inhibitors


#Tyrosine kinase inhibitors are #targeted_therapies for #cancer.

Tyrosine-kinase inhibitors include neratinib (Nerlynx), which is FDA-approved for the treatment of HER2-positive early breast cancer, and lapatinib (Tykerb), which is FDA-approved for the treatment of HER2-positive metastatic breast cancer.

Join with us in #Rome, Italy at #October15_16,2018 With our grand #World Congress on Breast Cancer

Save your #Dates and be a #Speaker for the conference.


contact us for queries regarding conference : breastcancer@pulsusevents.org | breastcancer@pulsusmeet.org 
submit an #Abstract on-https://bit.ly/2IaExiN 
Registration-https://bit.ly/2s5WVDn 
Visit the site for more details-https://bit.ly/2s8xD6O 
download the brochure-https://bit.ly/2rzvssM

No comments:

Post a Comment

Electromagnetic Fields May Help Prevent Spread of Breast Cancer Cells

Electromagnetic fields might help prevent some breast cancers from spreading to other parts of the body, new research has found. The stu...